Thursday, July 4, 2013

2013 Analysis of the Cell Surface Markers in Europe: Hospitals, Commercial Labs, Ambulatory Care Centers

2013 Analysis of the Cell Surface Markers in Europe: Hospitals, Commercial Labs, Ambulatory Care Centers

NEW YORK, July 4, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

2013 Analysis of the Cell Surface Markers in Europe: Hospitals, Commercial Labs, Ambulatory Care Centers
http://www.reportlinker.com/p01361269/2013-Analysis-of-the-Cell-Surface-Markers-in-Europe-Hospitals-Commercial-Labs-Ambulatory-Care-Centers.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Complete report $3,850. DataPack (test volumes, sales forecasts, supplier shares) $2,500.
The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, CD34 and other markers by country.
Rationale
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.

This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in five European countries, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by country and market segment.
The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 125 pages and 24 tables

Table of Contents

I. Introduction
II. Worldwide Market and Technology Overview
A. Lymphocyte Subclassification CD4/CD8/CD34
- Instrumentation and Reagent Test Kits
* BD
* Beckman Coulter/Danaher
* T Cells Diagnostics
B. CD34
C. Other Cell Markers
D. Instrumentation Review
1. Hematology Analyzers
a. Overview
- Electrical Aperture-Impedance Analyzers
- Light Scatter Analyzers
b. System Review
- Abbott
- Beckman Coulter/Danaher
- Biocode Hycel
- Drew-Scientific
- Horiba
- Menarini
- Nihon Kohden
- Siemens
- Sysmex
2. Flow Cytometers
a. Introduction
b. System Overview
- Becton Dickinson
- Beckman Coulter/Danaher
E. Current Market Needs and Future Demand
For Hematology Analyzers
F. Reagents and Controls
G. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
III. France : Forecasts by Test and Market Segment
IV. Germany : Forecasts by Test and Market Segment
V. Italy : Forecasts by Test and Market Segment
VI. Spain : Forecasts by Test and Market Segment
VII. U.K. : Forecasts by Test and Market Segment
VIII. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized
Testing Markets
1. Four Marketing Approaches
2. Product Complexity Factor
3. Customer Preference Factor
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
IX. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
X. Competitive Assessments
- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Iris/Danaher
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Roche
- Siemens
- Sysmex
XI. Appendix: Major Universities and Research
Centers Developing Hematology/Flow Cytometry
Technologies and Applications
France, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
France, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
France, Flow Cytometry Consumables Market
By Major Supplier
France, Flow Cytometry Instrument Market
By Major Supplier
France, Flow Cytometry Diagnostics Market
By Major Supplier
Germany, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Germany, Flow Cytometry Consumables Market
By Major Supplier
Germany, Flow Cytometry Instrument Market
By Major Supplier
Germany, Flow Cytometry Diagnostics Market
By Major Supplier
Italy, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Italy, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Italy, Flow Cytometry Consumables Market
By Major Supplier
Italy, Flow Cytometry Instrument Market
By Major Supplier
Italy, Flow Cytometry Diagnostics Market
By Major Supplier
Spain, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Spain, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Spain, Ambulatory Care Center Estimated
Cell Surface Marker Test Volume
Spain, Flow Cytometry Consumables Market
By Major Supplier
Spain, Flow Cytometry Instrument Market
By Major Supplier
Spain, Flow Cytometry Diagnostics Market
By Major Supplier
U.K., Hospital Laboratories Estimated
Cell Surface Marker Test Volume
U.K., Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
U.K., Flow Cytometry Consumables Market
By Major Supplier
U.K., Flow Cytometry Instrument Market
By Major Supplier
U.K., Flow Cytometry Diagnostics Market
By Major Supplier

To order this report:
In_Vitro_Diagnostic Industry:
2013 Analysis of the Cell Surface Markers in Europe: Hospitals, Commercial Labs, Ambulatory Care Centers

__________________________
Contact Clare: clare@reportlinker.com  
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker

RELATED LINKS
http://www.reportlinker.com


Source: www.prnewswire.com


From Around the Web
http://facebookgameshelp.com/index.php?do=/blog/2586/the-concealed-reality-regarding-safe-weight-loss-pills/
http://ecoles.ac-rouen.fr/encyclo/index.php?title=Discover_The_Critical_Details_On_Weight_Loss_Products
http://emiratesbizz.com/index.php?do=/blog/3983/the-puzzles-i-reveal-on-all-natural-weight-loss-supplements/
http://gateclub.net/blogs/viewstory/136490
http://hostmaster.terhorstnet.nl/wiki/The_Reasons_For_All_Natural_Slimming_Products

No comments:

Post a Comment